{
    "article_link": "https://doi.org/10.1038/s41467-023-42565-z",
    "data": [
        {
            "id": "data_1",
            "omics": "Epigenomics (Chromatin Accessibility)",
            "link": "https://gdc.cancer.gov/about-data/publications#/?groups=TARGET-ALL-P2&years=&order=desc",
            "format": "FASTQ/BAM",
            "source": "Genome Sequence Archive for Human (GSA-human)",
            "public_id": "HRA002815"
        },
        {
            "id": "data_2",
            "omics": "Epigenomics (Histone Modifications)",
            "link": "http://blueprint-data.bsc.es/#!/",
            "format": "FASTQ/BAM",
            "source": "Blueprint Epigenomic Consortium",
            "public_id": "S017E3"
        },
        {
            "id": "data_3",
            "omics": "Genomics (Whole Genome Sequencing)",
            "link": "https://gdc.cancer.gov/about-data/publications#/?groups=TARGET-ALL-P2&years=&order=desc",
            "format": "FASTQ/BAM",
            "source": "Genome Sequence Archive for Human (GSA-human)",
            "public_id": "HRA005668"
        },
        {
            "id": "data_4",
            "omics": "Transcriptomics (RNA-seq)",
            "link": "https://gdc.cancer.gov/about-data/publications#/?groups=TARGET-ALL-P2&years=&order=desc",
            "format": "FASTQ/BAM",
            "source": "TARGET project",
            "public_id": "phs000464"
        },
        {
            "id": "data_5",
            "omics": "Epigenomics (ChIP-seq for H3K27ac)",
            "link": "https://ega-archive.org/studies/EGAD00001002421",
            "format": "FASTQ/BAM",
            "source": "EGA database",
            "public_id": "EGAD00001002421"
        }
    ],
    "analyses": [
        {
            "id": "analysis_1",
            "analysis_name": "Chromatin Accessibility Landscape Characterization",
            "analysis_data": [
                "data_1"
            ],
            "label": {
                "B-ALL_subtype": [
                    "Hyperdiploidy",
                    "ETV6::RUNX1",
                    "TCF3::PBX1",
                    "KMT2A",
                    "BCR::ABL1",
                    "BCR::ABL1-like",
                    "ZNF384",
                    "PAX5alt",
                    "TCF3::HLF",
                    "Hypodiploidy",
                    "MEF2D",
                    "B-other"
                ]
            }
        },
        {
            "id": "analysis_2",
            "analysis_name": "Comparison with B-cell Progenitors",
            "analysis_data": [
                "data_1",
                "data_2"
            ],
            "label": {
                "Cell_type": [
                    "B-ALL",
                    "pre-pro B cells",
                    "pro B cells"
                ]
            }
        },
        {
            "id": "analysis_3",
            "analysis_name": "Subtype-specific Chromatin Accessibility",
            "analysis_data": [
                "data_1"
            ],
            "label": {
                "B-ALL_subtype": [
                    "Hyperdiploidy",
                    "ETV6::RUNX1",
                    "TCF3::PBX1",
                    "KMT2A",
                    "BCR::ABL1",
                    "BCR::ABL1-like",
                    "ZNF384",
                    "B-other"
                ]
            }
        },
        {
            "id": "analysis_4",
            "analysis_name": "Allele-specific Open Chromatin (ASOC) Analysis",
            "analysis_data": [
                "data_1",
                "data_3"
            ],
            "label": {
                "Genotype": [
                    "C/T",
                    "G/A"
                ]
            }
        },
        {
            "id": "analysis_5",
            "analysis_name": "Relapse-related Chromatin Accessibility Alterations",
            "analysis_data": [
                "data_1",
                "data_3"
            ],
            "label": {
                "Treatment_phase": [
                    "Diagnosis",
                    "Relapse"
                ]
            }
        },
        {
            "id": "analysis_6",
            "analysis_name": "Survival Analysis (Relapse-free Survival)",
            "analysis_data": [
                "data_1",
                "data_4"
            ],
            "label": {
                "Survival_group": [
                    "Group A",
                    "Group B"
                ]
            }
        }
    ],
    "results": [
        {
            "analysis_id": "analysis_1",
            "metrics": "Proportion of ACRs in Quies regions",
            "value": "27.95%",
            "features": [
                "IL7R",
                "TCF3",
                "RHOA",
                "ELL",
                "MYC"
            ]
        },
        {
            "analysis_id": "analysis_2",
            "metrics": "Shared ACRs with B-cell progenitors",
            "value": "98.57% (pre-pro B), 98.35% (pro B)",
            "features": [
                "B-ALL-specific ACRs (585,248)",
                "Quies ACRs (54.94% overlap)"
            ]
        },
        {
            "analysis_id": "analysis_3",
            "metrics": "Subtype-specific ACRs",
            "value": "17,981 ACRs",
            "features": [
                "E2F6",
                "RUNX1",
                "KLF15",
                "MYB",
                "TCF3::PBX1",
                "ETV6::RUNX1"
            ]
        },
        {
            "analysis_id": "analysis_4",
            "metrics": "Leukemia-associated SNPs in ASOC regions",
            "value": "46 SNPs (7 recurrent: rs7090445, rs13401811)",
            "features": [
                "ARID5B",
                "BCL2L11",
                "MECOM",
                "HOXA9"
            ]
        },
        {
            "analysis_id": "analysis_5",
            "metrics": "Differential ACRs between diagnosis and relapse",
            "value": "5911 relapse-high ACRs (0.95%), 1423 relapse-low ACRs (0.23%)",
            "features": [
                "Imatinib",
                "Etoposide",
                "Doxorubicin",
                "Dasatinib"
            ]
        },
        {
            "analysis_id": "analysis_6",
            "metrics": "Log-rank test p-value",
            "value": "3.778e−10 (RFS), 5.585e−7 (OS)",
            "features": [
                "Hyperdiploidy cases in Group B",
                "Stem cell/myeloid progenitor-like genes (603 targets)"
            ]
        }
    ]
}